Generics - AstraZeneca, Mylan Laboratories

Filter

Popular Filters

Watson debuts generic Nexium in Europe; Mylan launches Amidate copy in USA

08-08-2012

US generics firm Watson Pharmaceuticals (NYSE: WPI) said yesterday that its third-party business Specifar…

AmidateAstraZenecaEuropeGastro-intestinalsGenericsHospiraMarkets & MarketingMylan LaboratoriesNeurologicalNexiumNorth AmericaRegulationWatson Pharmaceuticals

US Court upholds AstraZeneca Seroquel XR patent

30-03-2012

In some good news for the company, Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last night…

Anchen PharmaceuticalsAstraZenecaGenericsMylan LaboratoriesNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRTorrent Pharmaceuticals

Mylan gets OK for generic Crestor in Canada; Rottapharm deal looks dead

18-03-2012

The Canadian subsidiary of US generic drugmaker Mylan (Nasdaq: MYL) has received approval from Health…

AstraZenecaCardio-vascularCrestorEuropeGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaPharmaceuticalRegulationRottapharm

Company Spotlight

ImmunoGen

ImmunoGen

Back to top